|
1
|
McNally EM, Golbus JR and Puckelwartz MJ:
Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin
Invest. 123:19–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hershberger RE, Hedges DJ and Morales A:
Dilated cardiomyopathy: the complexity of a diverse genetic
architecture. Nat Rev Cardiol. 10:531–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Garcia-Pavia P, Cobo-Marcos M,
Guzzo-Merello G, Gomez-Bueno M, Bornstein B, Lara-Pezzi E, Segovia
J and Alonso-Pulpon L: Genetics in dilated cardiomyopathy.
Biomarkers Med. 7:517–533. 2013. View Article : Google Scholar
|
|
4
|
Koutalas E, Kanoupakis E and Vardas P:
Sudden cardiac death in non-ischemic dilated cardiomyopathy: a
critical appraisal of existing and potential risk stratification
tools. Int J Cardiol. 167:335–341. 2013. View Article : Google Scholar
|
|
5
|
Yoshikawa T: Contribution of acquired
factors to the pathogenesis of dilated cardiomyopathy. -The cause
of dilated cardiomyopathy: genetic or acquired? (acquired-side)-.
Circ J. 75:1766–1773. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kamisago M, Sharma SD, DePalma SR, Solomon
S, Sharma P, McDonough B, Smoot L, Mullen MP, Woolf PK, Wigle ED,
et al: Mutations in sarcomere protein genes as a cause of dilated
cardiomyopathy. N Engl J Med. 343:1688–1696. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arndt AK, Schafer S, Drenckhahn JD, Sabeh
MK, Plovie ER, Caliebe A, Klopocki E, Musso G, Werdich AA, Kalwa H,
et al: Fine mapping of the 1p36 deletion syndrome identifies
mutation of PRDM16 as a cause of cardiomyopathy. Am J Hum Genet.
93:67–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pankuweit S, Ruppert V, Jónsdóttir T,
Müller HH and Meyer T: German Competence Network of Heart Failure:
The HLA class II allele DQB1 0309 is associated with dilated
cardiomyopathy. Gene. 531:180–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wahbi K, Béhin A, Bécane HM, Leturcq F,
Cossée M, Laforêt P, Stojkovic T, Carlier P, Toussaint M, Gaxotte
V, et al: Dilated cardiomyopathy in patients with mutations in
anoctamin 5. Int J Cardiol. 168:76–79. 2013. View Article : Google Scholar
|
|
10
|
Ruppert V, Meyer T, Richter A, Maisch B
and Pankuweit S: German Competence Network of Heart Failure:
Identification of a missense mutation in the melusin-encoding
ITGB1BP2 gene in a patient with dilated cardiomyopathy. Gene.
512:206–210. 2013. View Article : Google Scholar
|
|
11
|
Agrawal PB, Pierson CR, Joshi M, Liu X,
Ravenscroft G, Moghadaszadeh B, Talabere T, Viola M, Swanson LC,
Haliloğlu G, et al: SPEG interacts with myotubularin, and its
deficiency causes centronuclear myopathy with dilated
cardiomyopathy. Am J Hum Genet. 95:218–226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsa LS, Sagurthi SR, Ananthapur V, Nalla
S and Nallari P: Endothelin 1 gene as a modifier in dilated
cardiomyopathy. Gene. 548:256–262. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pikkarainen S, Tokola H, Kerkelä R and
Ruskoaho H: GATA transcription factors in the developing and adult
heart. Cardiovasc Res. 63:196–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cai H, Katoh-Kurasawa M, Muramoto T,
Santhanam B, Long Y, Li L, Ueda M, Iglesias PA, Shaulsky G and
Devreotes PN: Nucleocytoplasmic shuttling of a GATA transcription
factor functions as a development timer. Science. 343:12495312014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Akazawa H and Komuro I: Cardiac
transcription factor Csx/Nkx2-5: Its role in cardiac development
and diseases. Pharmacol Ther. 107:252–268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Greulich F, Rudat C and Kispert A:
Mechanisms of T-box gene function in the developing heart.
Cardiovasc Res. 91:212–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oka T, Xu J and Molkentin JD:
Re-employment of developmental transcription factors in adult heart
disease. Semin Cell Dev Biol. 18:117–131. 2007. View Article : Google Scholar
|
|
18
|
Garg V, Kathiriya IS, Barnes R,
Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS,
Hirayama-Yamada K, Joo K, et al: GATA4 mutations cause human
congenital heart defects and reveal an interaction with TBX5.
Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rajagopal SK, Ma Q, Obler D, Shen J,
Manichaikul A, Tomita-Mitchell A, Boardman K, Briggs C, Garg V,
Srivastava D, et al: Spectrum of heart disease associated with
murine and human GATA4 mutation. J Mol Cell Cardiol. 43:677–685.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang YQ, Wang J, Liu XY, Chen XZ, Zhang W
and Wang XZ: Mutation spectrum of GATA4 associated with congenital
atrial septal defects. Arch Med Sci. 9:976–983. 2013. View Article : Google Scholar
|
|
21
|
Yang YQ, Gharibeh L, Li RG, Xin YF, Wang
J, Liu ZM, Qiu XB, Xu YJ, Xu L, Qu XK, et al: GATA4
loss-of-function mutations underlie familial tetralogy of Fallot.
Hum Mutat. 34:1662–1671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiang R, Fan LL, Huang H, Cao BB, Li XP,
Peng DQ and Xia K: A novel mutation of GATA4 (K319E) is responsible
for familial atrial septal defect and pulmonary valve stenosis.
Gene. 534:320–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang JQ, Li RG, Wang J, Liu XY, Xu YJ,
Fang WY, Chen XZ, Zhang W, Wang XZ and Yang YQ: Prevalence and
spectrum of GATA5 mutations associated with congenital heart
disease. Int J Cardiol. 165:570–573. 2013. View Article : Google Scholar
|
|
24
|
Wei D, Bao H, Zhou N, Zheng GF, Liu XY and
Yang YQ: GATA5 loss-of-function mutation responsible for the
congenital ventriculoseptal defect. Pediatr Cardiol. 34:504–511.
2013. View Article : Google Scholar
|
|
25
|
Wei D, Bao H, Liu XY, Zhou N, Wang Q, Li
RG, Xu YJ and Yang YQ: GATA5 loss-of-function mutations underlie
tetralogy of fallot. Int J Med Sci. 10:34–42. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi LM, Tao JW, Qiu XB, Wang J, Yuan F, Xu
L, Liu H, Li RG, Xu YJ, Wang Q, et al: GATA5 loss-of-function
mutations associated with congenital bicuspid aortic valve. Int J
Mol Med. 33:1219–1226. 2014.PubMed/NCBI
|
|
27
|
Huang RT, Xue S, Xu YJ, Zhou M and Yang
YQ: Somatic GATA5 mutations in sporadic tetralogy of Fallot. Int J
Mol Med. 33:1227–1235. 2014.PubMed/NCBI
|
|
28
|
Zheng GF, Wei D, Zhao H, Zhou N, Yang YQ
and Liu XY: A novel GATA6 mutation associated with congenital
ventricular septal defect. Int J Mol Med. 29:1065–1071.
2012.PubMed/NCBI
|
|
29
|
Huang RT, Xue S, Xu YJ and Yang YQ:
Somatic mutations in the GATA6 gene underlie sporadic tetralogy of
Fallot. Int J Mol Med. 31:51–58. 2013.
|
|
30
|
Schott JJ, Benson DW, Basson CT, Pease W,
Silberbach GM, Moak JP, Maron BJ, Seidman CE and Seidman JG:
Congenital heart disease caused by mutations in the transcription
factor NKX2-5. Science. 281:108–111. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang W, Meng H, Qiao Y, Pang S, Chen D
and Yan B: Two novel and functional DNA sequence variants within an
upstream enhancer of the human NKX2-5 gene in ventricular septal
defects. Gene. 524:152–155. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qu XK, Qiu XB, Yuan F, Wang J, Zhao CM,
Liu XY, Zhang XL, Li RG, Xu YJ, Hou XM, et al: A novel NKX2.5
loss-of-function mutation associated with congenital bicuspid
aortic valve. Am J Cardiol. 114:1891–1895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Heathcote K, Braybrook C, Abushaban L, Guy
M, Khetyar ME, Patton MA, Carter ND, Scambler PJ and Syrris P:
Common arterial trunk associated with a homeodomain mutation of
NKX2.6. Hum Mol Genet. 14:585–593. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ta-Shma A, El-lahham N, Edvardson S,
Stepensky P, Nir A, Perles Z, Gavri S, Golender J,
Yaakobi-Simhayoff N, Shaag A, et al: Conotruncal malformations and
absent thymus due to a deleterious NKX2-6 mutation. J Med Genet.
51:268–270. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao L, Ni SH, Liu XY, Wei D, Yuan F, Xu
L, Xin-Li Li RG, Qu XK, Xu YJ, et al: Prevalence and spectrum of
Nkx2.6 mutations in patients with congenital heart disease. Eur J
Med Genet. 57:579–586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang J, Mao JH, Ding KK, Xu WJ, Liu XY,
Qiu XB, Li RG, Qu XK, Xu YJ, Huang RT, et al: A novel NKX2.6
mutation associated with congenital ventricular septal defect.
Pediatr Cardiol. 36:646–656. 2015. View Article : Google Scholar
|
|
37
|
Baban A, Postma AV, Marini M, Trocchio G,
Santilli A, Pelegrini M, Sirleto P, Lerone M, Albanese SB, Barnett
P, et al: Identification of TBX5 mutations in a series of 94
patients with Tetralogy of Fallot. Am J Med Genet A.
164A:3100–3107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
McCulley DJ and Black BL: Transcription
factor pathways and congenital heart disease. Curr Top Dev Biol.
100:253–277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Andersen TA, Troelsen KL and Larsen LA: Of
mice and men: molecular genetics of congenital heart disease. Cell
Mol Life Sci. 71:1327–1352. 2014. View Article : Google Scholar :
|
|
40
|
Wang J, Sun YM and Yang YQ: Mutation
spectrum of the GATA4 gene in patients with idiopathic atrial
fibrillation. Mol Biol Rep. 39:8127–8135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang XH, Huang CX, Wang Q, Li RG, Xu YJ,
Liu X, Fang WY and Yang YQ: A novel GATA5 loss-of-function mutation
underlies lone atrial fibrillation. Int J Mol Med. 31:43–50.
2013.
|
|
42
|
Li J, Liu WD, Yang ZL and Yang YQ: Novel
GATA6 loss-of-function mutation responsible for familial atrial
fibrillation. Int J Mol Med. 30:783–790. 2012.PubMed/NCBI
|
|
43
|
Xie WH, Chang C, Xu YJ, Li RG, Qu XK, Fang
WY, Liu X and Yang YQ: Prevalence and spectrum of Nkx2.5 mutations
associated with idiopathic atrial fibrillation. Clinics (Sao
Paulo). 68:777–784. 2013. View Article : Google Scholar
|
|
44
|
Huang RT, Xue S, Xu YJ, Zhou M and Yang
YQ: A novel NKX2.5 loss-of-function mutation responsible for
familial atrial fibrillation. Int J Mol Med. 31:1119–1126.
2013.PubMed/NCBI
|
|
45
|
Perera JL, Johnson NM, Judge DP and
Crosson JE: Novel and highly lethal NKX2.5 missense mutation in a
family with sudden death and ventricular arrhythmia. Pediatr
Cardiol. 35:1206–1212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yu H, Xu JH, Song HM, Zhao L, Xu WJ, Wang
J, Li RG, Xu L, Jiang WF, Qiu XB, et al: Mutational spectrum of the
NKX2-5 gene in patients with lone atrial fibrillation. Int J Med
Sci. 11:554–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang J, Zhang DF, Sun YM, Li RG, Qiu XB,
Qu XK, Liu X, Fang WY and Yang YQ: NKX2-6 mutation predisposes to
familial atrial fibrillation. Int J Mol Med. 34:1581–1590.
2014.PubMed/NCBI
|
|
48
|
Postma AV, van de Meerakker JB, Mathijssen
IB, Barnett P, Christoffels VM, Ilgun A, Lam J, Wilde AA, Lekanne
Deprez RH and Moorman AF: A gain-of-function TBX5 mutation is
associated with atypical Holt-Oram syndrome and paroxysmal atrial
fibrillation. Circ Res. 102:1433–1442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hong K and Xiong Q: Genetic basis of
atrial fibrillation. Curr Opin Cardiol. 29:220–226. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li RG, Li L, Qiu XB, Yuan F, Xu L, Li X,
Xu YJ, Jiang WF, Jiang JQ, Liu X, et al: GATA4 loss-of-function
mutation underlies familial dilated cardiomyopathy. Biochem Biophys
Res Commun. 439:591–596. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhao L, Xu JH, Xu WJ, Yu H, Wang Q, Zheng
HZ, Jiang WF, Jiang JF and Yang YQ: A novel GATA4 loss-of-function
mutation responsible for familial dilated cardiomyopathy. Int J Mol
Med. 33:654–660. 2014.
|
|
52
|
Zhang XL, Dai N, Tang K, Chen YQ, Chen W,
Wang J, Zhao CM, Yuan F, Qiu XB, Qu XK, et al: GATA5
loss-of-function mutation in familial dilated cardiomyopathy. Int J
Mol Med. 35:763–770. 2015.
|
|
53
|
Xu L, Zhao L, Yuan F, Jiang WF, Liu H, Li
RG, Xu YJ, Zhang M, Fang WY, Qu XK, et al: GATA6 loss-of-function
mutations contribute to familial dilated cardiomyopathy. Int J Mol
Med. 34:1315–1322. 2014.PubMed/NCBI
|
|
54
|
Costa MW, Guo G, Wolstein O, Vale M,
Castro ML, Wang L, Otway R, Riek P, Cochrane N, Furtado M, et al:
Functional characterization of a novel mutation in NKX2-5
associated with congenital heart disease and adult-onset
cardiomyopathy. Circ Cardiovasc Genet. 6:238–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yuan F, Qiu XB, Li RG, Qu XK, Wang J, Xu
YJ, Liu X, Fang WY, Yang YQ and Liao DN: A novel NKX2-5
loss-of-function mutation predisposes to familial dilated
cardiomyopathy and arrhythmias. Int J Mol Med. 35:478–486.
2015.
|
|
56
|
Zhang XL, Qiu XB, Yuan F, Wang J, Zhao CM,
Li RG, Xu L, Xu YJ, Shi HY, Hou XM, et al: TBX5 loss-of-function
mutation contributes to familial dilated cardiomyopathy. Biochem
Biophys Res Commun. 459:166–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li J, Liu WD, Yang ZL, Yuan F, Xu L, Li RG
and Yang YQ: Prevalence and spectrum of GATA4 mutations associated
with sporadic dilated cardiomyopathy. Gene. 548:174–181. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Elliott P, O’Mahony C, Syrris P, Evans A,
Rivera Sorensen C, Sheppard MN, Carr-White G, Pantazis A and
McKenna WJ: Prevalence of desmosomal protein gene mutations in
patients with dilated cardiomyopathy. Circ Cardiovasc Genet.
3:314–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Richardson P, McKenna W, Bristow M, Maisch
B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I,
et al: Report of the 1995 World Health Organization/International
Society and Federation of Cardiology Task Force on the Definition
and Classification of cardiomyopathies. Circulation. 93:841–842.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hiroi Y, Kudoh S, Monzen K, Ikeda Y,
Yazaki Y, Nagai R and Komuro I: Tbx5 associates with Nkx2-5 and
synergistically promotes cardiomyocyte differentiation. Nat Genet.
28:276–280. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
61
|
Stennard FA, Costa MW, Elliott DA, Rankin
S, Haast SJ, Lai D, McDonald LP, Niederreither K, Dolle P, Bruneau
BG, et al: Cardiac T-box factor Tbx20 directly interacts with
Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the
developing heart. Dev Biol. 262:206–224. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Plageman TF Jr and Yutzey KE: T-box genes
and heart development: putting the ‘T’ in heart. Dev Dyn.
232:11–20. 2005. View Article : Google Scholar
|
|
63
|
Bruneau BG, Logan M, Davis N, Levi T,
Tabin CJ, Seidman JG and Seidman CE: Chamber-specific cardiac
expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev
Biol. 211:100–108. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Bruneau BG, Nemer G, Schmitt JP, Charron
F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman
CE, et al: A murine model of Holt-Oram syndrome defines roles of
the T-box transcription factor Tbx5 in cardiogenesis and disease.
Cell. 106:709–721. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Misra C, Chang SW, Basu M, Huang N and
Garg V: Disruption of myocardial Gata4 and Tbx5 results in defects
in cardiomyocyte proliferation and atrioventricular septation. Hum
Mol Genet. 23:5025–5035. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Kirk EP, Sunde M, Costa MW, Rankin SA,
Wolstein O, Castro ML, Butler TL, Hyun C, Guo G, Otway R, et al:
Mutations in cardiac T-box factor gene TBX20 are associated with
diverse cardiac pathologies, including defects of septation and
valvulogenesis and cardiomyopathy. Am J Hum Genet. 81:280–291.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
67
|
Böhm J, Heinritz W, Craig A, Vujic M,
Ekman-Joelsson BM, Kohlhase J and Froster U: Functional analysis of
the novel TBX5 c.1333delC mutation resulting in an extended TBX5
protein. BMC Med Genet. 9:882008. View Article : Google Scholar : PubMed/NCBI
|
